Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinbao Pill for brain injury after cardiopulmonary resuscitation
ChiCTR2400086690Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Xinbao Pill in hypoxic-ischemic encephalopathy (HIE) and post-cardiac arrest syndrome (PCAS) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Survival with a favorable neurological outcome at discharge and APACHE II score. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
Xinbao Pill
03
Conditions
hypoxic-ischemic encephalopathy (HIE)post-cardiac arrest syndrome (PCAS)
Beyond the preview
Go deeper on ChiCTR2400086690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086690.